The Recall Desk

Category

Drug recalls

FDA recalls of prescription and over-the-counter drugs.

About drug recalls

FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.

The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.

If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.

1–25 of 17978

  • SevereFDA (Drugs)·D-0786-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling Levothyroxine Sodium 300 mcg tablets because they may contain less active ingredient than labeled.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0832-2026·2026-09-02

    B. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter

    B. Braun Medical Inc. is recalling 23,688 bags of Lactated Ringer's Injection USP due to the presence of particulate matter.

    Product
    LACTATED RINGERS — LACTATED RINGERS (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0776-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 50 mcg tablets nationwide because they may contain less than the labeled amount of active ingredient.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0778-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium tablets because they may contain less active ingredient than labeled.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0785-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 200 mcg tablets because they are subpotent. The recall covers distribution nationwide in the United States.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0803-2026·2026-09-02

    ACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter

    Mallinckrodt is recalling ACTHAR Gel vials due to the presence of glass and stopper pieces. Patients should stop using the product and contact their healthcare provider.

    Product
    ACTHAR — ACTHAR (REPOSITORY CORTICOTROPIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0827-2026·2026-09-02

    Fresenius Kabi Recalls Tyenne Injection Due to Glass Particles

    Fresenius Kabi is recalling Tyenne (tocilizumab-aazg) injection vials because an internal investigation found the presence of glass particles.

    Product
    TYENNE — TYENNE (TOCILIZUMAB-AAZG)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0779-2026·2026-09-02

    Accord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 100 mcg tablets because they may contain less active ingredient than labeled.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0790-2026·2026-09-02

    Zicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures

    Church & Dwight is recalling Zicam Cold Remedy Nasal Swabs because FDA inspections found out-of-limit microbiological testing results at the contract manufacturer.

    Product
    Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton, Zinc-Free Homeopathic, Distributed by Church & Dwight Co. Inc., Ewing, NJ 08628, UPC 732216301205.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0782-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is recalling specific lots of Levothyroxine Sodium 137 mcg tablets because they may contain less than the labeled amount of active ingredient.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0781-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they are subpotent. The recall is ongoing nationwide.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0784-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium tablets because they may contain less active ingredient than labeled.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0780-2026·2026-09-02

    Accord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 112 mcg tablets because they are subpotent. The recall covers nationwide distribution.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0777-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 75 mcg tablets nationwide because they may contain less than the labeled amount of active ingredient.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·N/A·2026-09-02

    Beak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination

    Beak & Skiff Sanitizer Alcohol Antiseptic 80% is being recalled because FDA analysis found acetaldehyde above specification limits in the product. The recall affects bottles distributed in New York and through online sales.

    Product
    Ibuprofen, 150 mg per 7.5 mL, Delivers: 7.5 mL, Conc: 20 mg/mL, Oral Suspension, 12mL Oral Syringes, Berry Flavor/Alcohol Free, Mfg By: MCNEIL, Pkg by: Safecor, Woburn, MA
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0831-2026·2026-09-02

    Hikma Recalls Ramipril Capsules Due to Process Impurity

    Hikma Pharmaceuticals is recalling specific lots of Ramipril 10 mg capsules because they failed impurity specifications for dicyclohexylurea.

    Product
    RAMIPRIL — RAMIPRIL (RAMIPRIL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0789-2026·2026-09-02

    Lupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures

    Lupin Pharmaceuticals is recalling Clobetasol Propionate Cream 0.05% because it failed content uniformity specifications. The recall covers 5,082 tubes distributed nationwide.

    Product
    CLOBETASOL PROPIONATE — CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0804-2026·2026-09-02

    Apotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing

    Apotex Corp. is recalling 6,972 bottles of Paxil CR 37.5mg tablets because the product failed dissolution specifications and 24-month stability testing.

    Product
    PAXIL — PAXIL (PAROXETINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0783-2026·2026-09-02

    Accord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide

    Accord Healthcare is voluntarily recalling specific lots of Levothyroxine Sodium 150 mcg tablets because they may contain less active ingredient than labeled.

    Product
    LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0788-2026·2026-08-26

    Fresenius Kabi Recalls Morphine Syringes Due to Labeling Error

    Fresenius Kabi is recalling 625,500 Morphine Sulfate syringes because some were mislabeled and contained Dilaudid instead.

    Product
    MORPHINE SULFATE — MORPHINE SULFATE (MORPHINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0802-2026·2026-08-26

    FDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter

    American Regent, Inc. is recalling 43,460 vials of Nicardipine Hydrochloride Injection due to the presence of particulate matter, including hair, glass, and paraformaldehyde.

    Product
    NICARDIPINE HYDROCHLORIDE — NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0795-2026·2026-08-26

    American Regent Recalls Atropine Sulfate Injection Due to Particulate Matter

    American Regent, Inc. is recalling Atropine Sulfate injection vials because they contain particulate matter, including hair, glass, and paraformaldehyde.

    Product
    ATROPINE SULFATE — ATROPINE SULFATE (ATROPINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide

Looking for a different category? Browse all recalls.